SomnoMed Ltd

RJV

Company Profile

  • Business description

    SomnoMed Ltd provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is engaged in commercializing SomnoDent Mandibular Advancement Splint (MAS) and other oral devices for sleep-related disorders in Australia and overseas. The other products in the company's portfolio include SomMorning Repositioner; SomnoBrux splint, a custom-fit, acrylic splint (dental guard) for upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs cleaning tablets that have been developed to clean oral appliances. Geographically, the company generates maximum revenue from Europe, followed by North America and the Asia Pacific region.

  • Contact

    20 Clarke Street
    Level 3
    Crows Nest
    SydneyNSW2065
    AUS

    T: +61 294670400

    https://www.somnomed.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2027

    Employees

    22

Stocks News & Analysis

stocks

Avoid these overvalued ASX shares

The two shares with the highest price to fair value in our Australian coverage.
stocks

Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?

Watching AI monetization, capex’s impact on margins, and guidance on Azure.
stocks

Lithium’s latest drop and what it means for ASX investors

Volatility returns to the lithium market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,997.507.300.08%
CAC 408,363.1423.030.28%
DAX 4025,011.35164.660.66%
Dow JONES (US)52,224.64385.380.74%
FTSE 10010,585.9161.150.58%
HKSE24,880.71251.58-1.00%
NASDAQ25,837.21329.131.29%
Nikkei 22566,264.7032.520.05%
NZX 50 Index13,763.18107.150.78%
S&P 5007,509.2065.920.89%
S&P/ASX 2008,815.308.800.10%
SSE Composite Index3,866.772.410.06%

Market Movers